NYS-15734-90257
2 vaccinations
2 coded responses
4 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 322 / FL
- Registered
- 2021-02-10
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-23
Dose 1 — Pfizer-BioNTech
-
2021-01-13
Dose 2 — Pfizer-BioNTech
-
2021-02-10
Registered in v-safe
-
2021-02-10
Survey response — 28 day, dose 2MedDRA: Abortion spontaneous, Office visit — Feeling: Good · Get care from a doctor or other healthcare professionalMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-02-10
Report sent to call center — 28 day, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-02-19
- 2021-02-24
-
2021-03-02
Call successfulParticipant prefers to complete VAERS report online
-
2021-07-16
Survey response — 6 month, dose 2MedDRA: Pregnancy — Feeling: GoodMedDRA releases: 2021-09,2024-11 · check-in answers available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Pfizer-BioNTech | |
| 2 | 2021-01-13 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-02-10 | Successful 2021-03-02 |
Participant prefers to complete VAERS report online |
Free text
Release 4
Symptoms: Miscarriage
Healthcare visit (other): Obstetrics appt
Release 9
Symptoms: New pregnancy
Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Abortion spontaneous | ✓ | ✓ | ✓ |
| SD | Pregnancy | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release